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Background: In previous study we showed that caspase-2 plays the role of an apical caspase in cell death induction
by taxanes in breast cancer cells. This study deals with the role of other caspases. We tested breast cancer cell lines
SK-BR-3 (functional caspase-3) and MCF-7 (nonfunctional caspase-3).
Methods and results: Using western blot analysis we demonstrated the activation of initiator caspase-8 and -9 as well
as executioner caspase-6 and -7 in both tested cell lines after application of taxanes (paclitaxel, SB-T-1216) at death-
inducing concentrations. Caspase-3 activation was also found in SK-BR-3 cells. Employing specific siRNAs after taxane
application, suppression of caspase-3 expression significantly increased the number of surviving SK-BR-3 cells. Inhibition
of caspase-7 expression also increased the number of surviving SK-BR-3 and MCF-7 cells. On the other hand,
suppression of caspase-8 and caspase-9 expression had no significant effect on cell survival. However, caspase-9
seemed to be involved in the activation of caspase-3 and caspase-7. Caspase-3 and caspase-7 appeared to activate
mutually. Furthermore, we observed a significant decrease in mitochondrial membrane potential (flow cytometric
analysis) and cytochrome c release (confocal microscopy, western blot after cell fractionation) from mitochondria
in SK-BR-3 cells. No such changes were observed in MCF-7 cells after taxane treatment.
Conclusion: We conclude that the activation of apical caspase-2 results in the activation of caspase-3 and -7
without the involvement of mitochondria. Caspase-9 can be activated directly via caspase-2 or alternatively after
cytochrome c release from mitochondria. Subsequently, caspase-9 activation can also lead to caspase-3 and -7
activations. Caspase-3 and caspase-7 activate mutually. It seems that there is also a parallel pathway involving
mitochondria that can cooperate in taxane-induced cell death in breast cancer cells.
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Taxanes are known mitotic poisons. There are two taxanes
currently used in cancer therapy, paclitaxel (Taxol®) of
natural origin and semi synthetic docetaxel (Taxotere®).
They are routinely used in chemotherapy of solid tu-
mors, e.g. breast cancer, ovary cancer, lung cancer and
prostate cancer [1]. Unfortunately, resistance of cancer
cells to clinically used taxanes (classical taxanes) be-
came a problem. Novel taxanes have been developed in
order to overcome resistance of cancer cells [2-4].
Some of these novel taxanes are significantly more
effective in resistant cancer cells [5,6].* Correspondence: jan.kovar@lf3.cuni.cz
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unless otherwise stated.Taxanes bind to the β subunit of the tubulin heterodi-
mer and prevent depolymerization of microtubules. The
stabilization of microtubules blocks progression through
the M phase of the cell cycle [7,8]. This state of mitotic
arrest normally results in cell death and it is supposedly
associated with mitotic catastrophe, which has been ob-
served by many authors in taxanes-treated cells [9-12].
Although there are numerous studies concerning taxane-
induced cell death in cancer cells, the molecular mechan-
ism remains elusive [12-14].
It is well known, that functional caspases are required
for completing apoptosis after various stimuli. Initiator
caspase-9, -8, -10, -2 are involved in apoptosis induction
and executioner caspase-3, -6 and -7 are involved in
apoptosis execution. The activation of various caspases
has been observed after taxane application in many typesThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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often associated with the death receptor signaling path-
way, has been found in cells treated with taxanes [15,16].
In contrast, the role of caspase-8, apart from its involve-
ment in certain amplification loops, has been seriously
questioned, particularly in regard to melanoma cancer
cells [13,15]. The activity of caspase-10, which, together
with caspase-8, is involved in the extrinsic apoptotic
pathway, has been observed in human leukemia cells
after taxane application. However it was not associated
with the activation of death receptors [17].
Caspase-2 is a highly conservative protease and it is
known to be involved in cell death induction by several
different stimuli, e.g. heat shock, growth factors with-
drawal or cytoskeleton damage [18]. It is often activated
within a cytoplasmic complex, containing in addition
PIDD protein and RAIDD protein, referred to as a PID-
Dosome [19]. Recently, several laboratories, including
ours have reported that caspase-2 appears to play a piv-
otal role in taxane-induced cell death [13,20,21].
Initiator caspase-9 is involved in the mitochondrial
pathway of apoptosis induction and its activity has been
found in several cancer cell lines [14,16,22] and also in
non-cancer cells [23] after taxane application. It indi-
cates that mitochondria can play an important role in
the taxane-induced apoptosis at least in certain cancer
cell lines [9,24]. Taxanes have also been found to induce
the release of cytochrome c from isolated mitochondria
[25] as well as from mitochondria in cancer cells [26,27]
or embryonic cells [21]. The release of cytochrome c is a
hallmark of apoptosis induction via the intrinsic apop-
totic pathway. Another significant feature is decreasing
mitochondrial membrane potential (Δψm). Some studies
in melanoma and prostate cancer cells have observed
decreasing Δψm after taxane treatment [13,28].
The activation of the key executive caspase-3 and/or
cleavage of its substrate PARP have been observed
in many cancer cell types after taxane application
[12,14,16]. On the other hand, the role of caspase-6
and -7 in cell death induction remains somewhat unclear
[17,29]. However, activation of caspase-7 has been de-
tected in breast cancer cells after taxane exposure [30]
as well as after combination treatments [31].
In our previous study, we described the activation of
caspase-8, -9 and -3 in sensitive and resistant breast can-
cer cells after apoptosis induction by paclitaxel, the
novel taxane SB-T-1216 as well as certain novel fluori-
nated taxanes. We observed that cytochrome c was re-
leased from the mitochondria in one of the tested cancer
cell lines. We also showed that caspase-2 was signifi-
cantly involved in taxane-induced cell death in breast
cancer cells [5,12]. Caspase-2 affected the activation of
caspase-3, -7, -8 and -9. Thus caspase-2 seemed to play
the role of an apical caspase [20].In the present study we tested the role of individual
caspases in taxane-induced cell death in breast cancer
cells. We tested two breast cancer cell lines, SK-BR-3
and MCF-7. It is known that functional p53 is absent in
SK-BR-3 cells but present in MCF-7 cells. On the other
hand, SK-BR-3 cells are known to have functional
caspase-3 while MCF-7 cells are deficient in functional
caspase-3 [32,33]. Such differences in proteins involved
in apoptosis facilitated elucidation of the role of individ-
ual caspases in taxane-induced cell death. We found that
the activation of apical caspase-2 led to the activation of
executioner caspase-3 and −7 without the mitochondria
involvement. Although a parallel pathway involving cyto-
chrome c release and caspase-9 activation may also be
involved.
Results
Effect of taxanes on caspase-3 activation
In order to assess caspase-3 activation in SK-BR-3 cells
after taxane application (MCF-7 cells have no functional
caspase-3), we tested the time course of procaspase-3
cleavage using western blot analysis.
Procaspase-3 levels decreased significantly 36 h after
application of both taxanes at death-inducing concentra-
tion (100 nM in SK-BR-3 cells, see “Materials and
methods”). After 48 h, the level of procaspase-3 in SK-
BR-3 cells was extremely low (data not shown). The
decrease of procaspase-3 levels correlated with dramatic-
ally increased levels of the cleaved form of caspase-3
which occurred 36 h after taxane application. However,
low levels of cleaved caspase-3 were detectable 24 h after
taxanes application (Figure 1A). The time course of
caspase-3 activation is in agreement with our finding
that most of SK-BR-3 cells are dead before 48 h of tax-
ane treatment (our unpublished data).
Using western blot analysis, the time course of the
levels of caspase-3 substrate PARP was also assessed. A
significant decrease in PARP levels after 36 h as well as
significant increase in cleaved PARP levels after 24 h and
36 h corresponded with caspase-3 activation after taxane
application (Figure 1B). In MCF-7 cells, the cleavage of
PARP was also detected 36 h after taxane application
(data not shown).
Effect of taxanes on caspase-6 and -7 activations
In order to assess the activation of other executioner
caspases (caspase-6 and -7) in both studied cell lines
after taxane application, we tested the time course of
procaspase-6 and -7 cleavage using western blot analysis.
Procaspase-6 levels decreased somewhat 36 h after the
application of taxanes at death-inducing concentration
(100 nM) in SK-BR-3 cells. Some decrease was also seen
24 h after the application. Concerning MCF-7 cells,
similar effect was seen at least 60 h after taxane
Figure 1 Effect of paclitaxel and SB-T-1216 on the activation and activity of caspase-3 in SK-BR-3 cells. After 0, 12, 24 and 36 h of incubation
with paclitaxel or SB-T-1216 (100 nM), levels of (A) procaspase-3 and cleaved caspase-3 as well as (B) levels of PARP were determined using western
blot analysis and relevant antibodies (see “Materials an methods”). Actin levels were used to confirm equal protein loading. The data shown were
obtained in one representative experiment of two independent experiments.
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MCF-7 cells, see “Materials and methods”). The decrease
of procaspase-6 levels in SK-BR-3 cells correlated
roughly with increased levels of the cleaved form of
caspase-6 24 h and 36 h after taxanes application. In
MCF-7 cells, cleaved caspase-6 was seen from 36 h to
60 h after application (Figure 2A).
Procaspase-7 levels decreased slightly 36 h after taxane
application in SK-BR-3 cells. In MCF-7 cells, there was
also certain decrease in procaspase-7 level 60 h after tax-
ane application. Increased levels of the cleaved form of
caspase-7 were detected 24 h and particularly 36 h after
taxane application in SK-BR-3 cells and from 24 h to48 h or even 60 h in MCF-7 cells (Figure 2B). The time
course of caspase-6 and -7 activations is also in agree-
ment with our finding that most of cells are dead before
48 h of taxane treatment (our unpublished data).
Effect of taxanes on caspase-8 and -9 activations
Using western blot analysis, we assessed the activation of
initiator caspase-8 and -9 after taxane application by
testing the time course of procaspase-8 and -9 cleavages.
Procaspase-8 levels decreased 36 h after the applica-
tion of both taxanes at death-inducing concentration
(100 nM) in SK-BR-3 cells. Concerning MCF-7 cells, a
decrease in procaspase-8 levels after the application of
Figure 2 (See legend on next page.)
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Figure 2 Effect of paclitaxel and SB-T-1216 on (A) the activation of caspase-6 and (B) the activation of caspase-7 in SK-BR-3 and MCF-7
cells. After 0, 12, 24, 36, 48 and 60 h of incubation with paclitaxel or SB-T-1216 (100 nM for SK-BR-3 cells and 300 nM for MCF-7 cells), levels of
procaspases and cleaved caspases were determined using western blot analysis and relevant antibodies (see “Materials and methods”). Actin levels
were used to confirm equal protein loading. The data shown were obtained in one representative experiment of two independent experiments.
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not detected. The decrease of procaspase-8 levels in SK-
BR-3 cells correlated with increased levels of the cleaved
form of caspase-8 36 h after taxanes application. Cleaved
caspase-8 was seen in MCF-7 cells from 24 h to 60 h
after taxane application, in spite of the fact that the cleav-
age of procaspase-8 was not detected here (Figure 3A).
Regarding caspase-9, the decrease of procaspase-9
levels after taxane application was not clearly detected in
SK-BR-3 or MCF-7 cells. Increased levels of the cleaved
form of caspase-9 appeared 24 h after taxanes applica-
tion in SK-BR-3 cells. The increase was more pro-
nounced 36 h after the application. Cleaved caspase-9
levels were also seen from 24 h to 60 h after taxane ap-
plication in MCF-7 cells (Figure 3B). Similarly like in the
case of caspase-3, -6 and -7, the time course of caspase-
8 and -9 activations is in agreement with our finding
that cells are principally dead before 48 h of taxane
treatment (our unpublished data).
Effect of the inhibition of caspase-3, -7, -8 and -9 expression
on taxane induced cell death
Employing RNA interference, we assessed the effect of
specific inhibition of caspase-3, -7, -8 and -9 expressions
on cell death induction by taxane application.
First, the efficiency of the RNA interference was
tested. It revealed that inhibition of the expression of in-
dividual caspases was efficient enough in both SK-BR-3
and MCF-7 cells (Figure 4A). Furthermore, nonsense
siRNA or specific caspase siRNAs did not significantly
affect cell growth or survival in either cell line. Cell
transfected with siRNAs seemed to grow slightly slower
when compared with control cells (data not shown). In
spite of this fact, in the case of caspase-3 and -7 we were
able to detect significant increase of cell growth and sur-
vival after the inhibition of caspase expression by siRNA
application when cells were incubated with taxanes (see
below).
After 48 h of incubation with taxanes at death-
inducing concentrations (100 nM), inhibition of caspase-
3 expression (81%) resulted in an approximately 6-fold
increase in the number of surviving SK-BR-3 cells. For
both taxanes, it represents a statistically significant in-
crease from about 2% to 12-14% of the number of cells
cultured without taxane. The inhibition of caspase-7 ex-
pression (81%) resulted in an approximately 4-fold in-
crease in the number of surviving SK-BR-3 cells after
48 h of incubation. It again represents a statisticallysignificant increase (from about 2% to 7-8%). After 96 h,
the effect of the inhibition of caspase-3 and caspase-7 ex-
pression was similar or even more pronounced. On the
other hand, we did not detect any significant effect of
caspase-8 (94%) or caspase-9 (70%) suppression on cell
death induction by taxanes in SK-BR-3 cells (Figure 4B).
Concerning MCF-7 cells, inhibition of caspase-7 ex-
pression (81%) increased the number of surviving cells
by approximately 2-fold after 48-h incubation with tax-
anes at death-inducing concentration (300 nM). It was a
statistically significant increase from about 20% to about
40% of the number of cells cultured without taxane.
After 96 h, the effect of the inhibition of caspase-7 ex-
pression was very similar. We did not detect a significant
effect of caspase-8 (89%) and caspase-9 (61%) suppres-
sion on taxane-induced cell death in MCF-7 cells. Per-
haps there was a slight, although insignificant, increase
of the number of surviving cells linked to the inhibition
of caspase-9 expression (Figure 4B).
Effect of the inhibition of caspase-8, -9, -3 and -7 expression
on taxane induced activation of caspase-8, -9, -3, -7
Using the siRNA technique, we assessed the effect of
specific inhibition of caspase-3, -7, -8 and -9 expression
on the activation of caspase-8, -9, -3, and -7 after taxane
application. Inhibition efficiency of individual caspases is
mentioned above (or see “Materials and methods”). To
confirm caspase-2 role as an apical caspase [20], the
effect of specific inhibition of the expression of tested
caspases on procaspase-2 cleavage was also assessed
after taxane application. No significant effect was found
(Figure 5).
After 36-h incubation of SK-BR-3 cells with taxanes at
death inducing concentration (100 nM), subsequent
western blot analysis showed significantly decreased
cleavage of caspase-8, -9 and -7 due to inhibition of
caspase-3 expression. Decreased cleavage of caspase-3
was observed in response to inhibition of caspase-7 ex-
pression. Decreased cleavage of caspase-9 was seen in
response to inhibition of caspase-8 expression and de-
creased cleavage of caspase-3 and -7 linked to inhibition
of caspase-9 expression (Figure 5A).
Concerning MCF-7 cells after 36 h of incubation with
taxanes at death-inducing concentration (300 nM), in-
hibition of caspase-7 expression did not significantly
affect the cleavage of caspase-9 but it slightly affected
the cleavage of caspase-8. Inhibition of caspase-8 expres-
sion did not affect the cleavage of caspase-9 and -7.
Figure 3 (See legend on next page.)
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Figure 3 Effect of paclitaxel and SB-T-1216 on (A) the activation of caspase-8 and (B) the activation of caspase-9 in SK-BR-3 and MCF-7
cells. After 0, 12, 24, 36, 48 and 60 h of incubation with paclitaxel or SB-T-1216 (100 nM for SK-BR-3 cells and 300 nM for MCF-7 cells), levels of
procaspases and cleaved caspases were determined using western blot analysis and relevant antibodies (see “Materials and methods”). Actin levels
were used to confirm equal protein loading. The data shown were obtained in one representative experiment of two independent experiments.
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cleavage of caspase-8, but it significantly decreased the
cleavage of caspase-7 (Figure 5B).
Effect of taxanes on mitochondrial membrane potential
(Δψm)
We employed [DiOC6(3)] staining and subsequent flow
cytometry to assess the effect of taxanes on mitochon-
drial membrane potential (Δψm).
In SK-BR-3 cells, within 36 h of incubation with tax-
anes at death-inducing concentration (100 nM), Δψm de-
creased significantly close to a total collapse. On the
other hand, Δψm did not show any significant decrease
in MCF-7 during 60 h after taxane application. It clearly
demonstrated different responses of mitochondrial
membrane potential to taxane application in SK-BR-3
and MCF-7 cells (Figure 6).
Effect of taxanes on cytochrome c release
The effect of tested taxanes on cytochrome c release
from mitochondria was assessed using confocalFigure 4 Effect of inhibition of caspase-3, -7, -8 and -9 expression on
paclitaxel and SB-T-1216 application. (A) Efficiency of caspase suppressi
Levels of caspases were determined using western blot analysis and releva
confirm equal protein loading. (B) The effect of specific caspase siRNAs o
treatment (100 nM for SK-BR-3 cells and 300 nM for MCF-7 cells) is presen
well and prepared as described (see “Materials and methods”). After 48 and 96
and methods”). Each column represents the mean of 3 or 4 separate cultures ±
cultures with individual specific siRNAs and culture with no siRNA.microscopy and cell fractionation followed by western
blot analysis.
Confocal microscopy showed that cytochrome c was
mainly localized in the mitochondria of control SK-BR-3
as well as MCF-7 cells. After 36 h of incubation of SK-
BR-3 cells with taxanes at death-inducing concentration
(100 nM), cytochrome c was released from the mito-
chondria into the cytosol. However, in MCF-7 cells,
cytochrome c was still found within mitochondria 36 h
after taxane application (300 nM) (Figure 7A).
These results were confirmed using western blot ana-
lysis after cell fractionation. Cytochrome c was shown to
be mainly localized in the mitochondrial cell fraction in
both SK-BR-3 and MCF-7 cells before taxane applica-
tion. In SK-BR-3 cells, cytochrome c levels increased
rapidly in the cytosolic fraction 24 h and particularly
36 h after taxane application. In MCF-7 cells, cyto-
chrome c stayed mainly in the mitochondrial fraction
after taxane application. Thus, after taxane application,
cytochrome c is released from mitochondria only in SK-
BR-3 cells, but not in MCF-7 cells (Figure 7B).cell growth and survival of SK-BR-3 and MCF-7 cells after
on based on specific siRNAs in SK-BR-3 and MCF-7 cells is shown.
nt antibodies (see “Materials and methods”). Actin levels were used to
n the growth and survival of SK-BR-3 and MCF-7 cells after taxane
ted. The cells were seeded at 20 × 103 cells/100 μl of medium per
h of incubation, the number of living cells was determined (see “Materials
SEM. *P < 0.05, **P < 0.01 when comparing the number of living cells in
Figure 5 (See legend on next page.)
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Figure 5 Effect of the inhibition of caspase-3, -7, -8 and -9 expression on the activation of caspase-3, -7, -8 and -9 in (A) SK-BR-3 and
(B) MCF-7 cells after paclitaxel and SB-T-1216 application. Specific caspase-3 siRNA, caspase-7 siRNA, caspase-8 siRNA and caspase-9 siRNA
were used. Control cells were incubated without taxane and siRNA. After 36 h of incubation with the tested taxane (100 nM for SK-BR-3 cells and
300 nM for MCF-7 cells) and relevant specific siRNA, levels of cleaved caspases were determined using western blot analysis and relevant
antibodies (see “Materials and methods”). Actin levels were used to confirm equal protein loading. The data shown were obtained in one
representative experiment of two independent experiments.
SK-BR-3 MCF-7
Figure 6 Effect of paclitaxel and SB-T-1216 on the mitochondrial membrane potential (Δψm) in SK-BR-3 and MCF-7 cells. Control cells
were incubated without taxane. After 36 h (SK-BR-3) or 60 h (MCF-7) of incubation with tested taxane (100 nM for SK-BR-3 and 300 nM for MCF-7) the
mitochondrial membrane potential was assessed using flow cytometry analysis of cells after staining with [DiOC6(3)] (see “Materials and methods”).
The collapse of Δψm caused by the application of CCCP is shown (blank areas). The data shown were obtained in one representative experiment of
three independent experiments.
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Figure 7 Effect of paclitaxel and SB-T-1216 on cytochrome c release from mitochondria in SK-BR-3 and MCF-7 cells. (A) After 36 h of
incubation with tested taxane (100 nM for SK-BR-3 cells and 300 nM for MCF-7 cells), the localization of cytochrome c within the cells was detected
using confocal microscopy (see “Materials and methods”). Control cells were incubated without taxane. The localization of cytochrome c
(green), mitochondria (red), nuclei (blue) and the merge of cytochrome c, mitochondria and nuclei are shown. The data shown were obtained
in one representative experiment of three independent experiments. (B) After 0, 12, 24, 36, 48 and 60 h of incubation with tested taxane (100 nM for
SK-BR-3 cells and 300 nM for MCF-7 cells), levels of cytochrome c in mitochondrial (M) and cytosolic (C) fractions were determined using western blot
analysis and relevant antibodies (see “Materials and methods”). COX IV (integral mitochondrial protein) level was used to confirm proper fractionation.
MEK levels were used to confirm equal protein loading of cytosolic fraction. The data shown were obtained in one representative experiment of three
independent experiments.
Jelínek et al. Cancer Cell International  (2015) 15:8 Page 11 of 16Discussion
In our previous paper [20] we studied the role of
caspase-2 in taxane-induced cell death in breast cancer
cells. It was suggested that caspase-2 plays the role of an
apical caspase. This study deals with the role of other
caspases, i.e. initiator caspase-8 and -9 as well as execu-
tioner caspase-3 and -7 in taxane-induced cell death in
breast cancer cells. The relationship between activation
of individual caspases was of particular interest. We used
two breast cancer cell lines, SK-BR-3 (nonfunctional
p53, functional caspase-3) and MCF-7 (functional p53,
nonfunctional caspase-3) as an experimental model. We
previously reported that p53 is activated in MCF-7 cells
after taxane application. However, we did not observed
p53-induced increased expression of PIDD protein or
any other function of p53 in activation of caspase-2 that
plays important role in cell death induction [20]. The
role of p53 in apoptosis induction after taxane applica-
tion is also questioned because we did not find the acti-
vation of mitochondrial death pathway to have a decisive
role in cell death induction here. Importantly, apoptosis
was induced in both tested cell lines even SK-BR-3 have
no functional p53 [20]. Taken together, we do not sup-
pose p53 to play an important role in cell death induc-
tion after taxane application in tested breast cancer cells.
We tested two taxanes, classical (clinically used) pacli-
taxel and novel taxane SB-T-1216. The effect of both
taxanes was found to be very similar.
We found that caspase-8 was activated after taxane ap-
plication at death-inducing concentrations in both tested
cell lines (see Figure 3). However, the suppression of
caspase-8 expression did not affect cell survival after
taxane treatment at all (see Figure 4). Activation of other
caspases, especially the executioner caspases, was not
significantly affected in cells where caspase-8 expression
had been inhibited (see Figure 5). The role of caspase-8
in various types of cancer cells after taxane treatment
has been previously discussed in several reports [12,15].
Interestingly, caspase-8 activation was usually observed
only with the simultaneous activation of other initiator
caspases (caspase-2 and caspase-9) after taxane appli-
cation [12,16,22]. The role of caspase-8 in taxane-
induced cell death was questioned by Park et al. [17].
They did not find any significant role of caspase-8 intaxane-induced cell death in lymphoid cells. Similarly,
we suggest that caspase-8 does not play any significant
role in cell death induction by taxanes in breast cancer
cells.
On the contrary, caspase-2 seems to play a key role in
cell death induction by taxanes [20]. We and others have
shown that cancer as well as non-cancer cells without
functional caspase-2 were more resistant to taxanes
[13,20,21]. We showed that the inhibition of caspase-2
expression resulted in decreased activation of caspase-9,
-3 and -7 after taxane application in breast cancer cells
which implies that caspase-2 plays the role of an apical
caspase in these cells [20] (see Figure 8).
Taxanes have been shown to induce the mitochondrial
pathway of apoptosis induction by several authors
[5,9,23]. Also in this study, we observed significant
decreases of Δψm and cytochrome c release from mito-
chondria in SK-BR-3 cells after taxane application.
However, we did not detect any change in Δψm or cyto-
chrome c release in taxane-treated MCF-7 cells (see
Figures 6 and 7). Previous reports have shown that
cytochrome c was released from mitochondria and
Δψm decreased in certain types of cancer cells treated
with taxane [5,27]. On the other hand, other types of
cancer cells underwent cell death without cytochrome c
release from mitochondria [5]. Recently, the role of
cytochrome c in taxane-induced cell death was also
assessed by Li et al. [34]. They observed cytochrome c
release from mitochondria but cell death was induced
without cytochrome c involvement. Thus, it seems that
the mitochondrial pathway does not play an essential
role in apoptosis induction by taxanes, at least in cer-
tain types of cancer cells (see Figure 8).
Caspase-9 was activated in SK-BR-3 cells and a rela-
tively low degree of activation was also found in MCF-7
cells (see Figure 3). Activation of caspase-9 has been ob-
served by many authors in various types of cancer cells
after taxane treatment and it usually appeared together
with caspase-3 activation [12,16,35]. Concerning the
mechanism of caspase-9 activation following taxane
treatment, we suggest that there are at least two path-
ways involved. Caspase-9 can be activated in the cytosol
via the classical pathway after cytochrome c release from
mitochondria or it can be activated via caspase-2
Figure 8 Scheme showing suggested pathways leading to the activation of individual caspases during apoptosis induction by taxanes
in breast cancer cells. Solid lines represent the main pathway of apoptosis induction and dashed lines represent parallel pathways.
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Figure 8). Although cells were slightly protected against
cell death induction by the inhibition of caspase-9 ex-
pression, the effect on cell survival after taxane applica-
tion was not significant in both tested cell lines (see
Figure 4). Independence of cell death induction by tax-
anes in MCF-7 cells on caspase-9 activity was described
previously [36]. Using caspase-9 siRNA, we also found
some decreased activation of executioner caspase-3 and
-7 after taxane application (see Figure 5). Finally, we sug-
gest that caspase-9 could play a role in the parallel path-
way of executioner caspase-3 and -7 activations after
taxane application (see Figure 8).
Caspase-3 was activated and its substrate PARP was
cleaved in SK-BR-3 cells after taxane application (see
Figure 1). Caspase-3 was also found to be activated in
other cancer cell types after exposure to paclitaxel
[16,24,37] or docetaxel [38]. Inhibition of caspase-3 ex-
pression increased the number of surviving SK-BR-3
cells significantly (see Figure 4). Concerning MCF-7
cells, there are previous reports demonstrating thatoverexpression of caspase-3, after transfection of the
caspase-3 gene, increased the sensitivity of cells to pacli-
taxel [32]. On the other hand, caspase-3-independent
cell death has been also reported to occur in MCF-7
cells transfected by the caspase-3 gene after paclitaxel
application [36]. We also demonstrated that the suppres-
sion of caspase-3 expression decreased the activation of
caspase-7 (see Figure 5). It confirms that caspase-7 is a
caspase-3-activated caspase. Thus, caspase-3 seems to be
a universally important executioner caspase for taxane-
induced cell death in a variety of cancer cell types.
Executioner caspase-7 and caspase-6 were activated in
tested cell lines after taxane application (see Figure 2).
Caspase-7 activation was also observed during cell death
induction by zoledronic acid in breast cancer cells [39]
or in other types of cancer cells after paclitaxel applica-
tion [24,30]. We showed that the suppression of
caspase-7 expression significantly increased the number
of surviving SK-BR-3 as well as MCF-7 cells (see
Figure 4). MCF-7 cells without functional caspase-7 have
been recently described to be more resistant to paclitaxel
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caspase-7 expression led to a decrease of caspase-3 acti-
vation in SK-BR-3 cells (see Figure 5). Thus it seems that
caspase-3 and -7 cooperate in the later phases of apop-
tosis induction by taxanes via their mutual activation
(see Figure 8). Cooperation of caspase-3 and caspase-7
during cell death induction was recently described by
Brentnall et al. [41].
Conclusion
We can summarize that caspase-2 plays the key role of
an apical caspase in main death-inducing pathway after
taxane application in tested breast cancer cells. This
pathway leads from activated caspase-2 to the activation
of executioner caspase-3 and -7 without the involvement
of mitochondria. There is mutual activation of caspase-3
and -7. Furthermore, taxanes appear to be able to induce
cytochrome c release from mitochondria in some breast
cancer cells. In these cases caspase-9 is activated. How-
ever, caspase-9 can also be activated here without the
mitochondrial involvement, probably via caspase-2 acti-
vation. This parallel pathway represents another possibil-
ity for caspase-3 and caspase-7 activation. It suggests
that both pathways can cooperate in cell death induction
by taxanes in at least some types of breast cancer cells.
Materials and methods
Materials
Paclitaxel was obtained from Sigma-Aldrich (St. Louis,
MO, USA). SB-T-1216 was synthesized at the Institute
of Chemical Biology and Drug Discovery (Stony Brook,
NY, USA). Taxanes were dissolved in DMSO (tissue cul-
ture quality) to obtain a 1 mM stock solution.
For western blot analysis, the following primary anti-
bodies were used: mouse monoclonal antibody against
caspase-3 (#9668), rabbit polyclonal antibody against
cleaved caspase-3 (#9661), rabbit polyclonal antibody
against caspase-6 (#9762), rabbit polyclonal antibody
against cleaved caspase-6 (#9761), rabbit polyclonal
antibody against caspase-7 (#9492), rabbit polyclonal
antibody against cleaved caspase-7 (#9491), mouse
monoclonal antibody against caspase-8 (#9746), rabbit
monoclonal antibody against cleaved caspase-8 (#9496),
rabbit polyclonal antibody against caspase-9 (#9502),
rabbit polyclonal antibody against cleaved caspase-9
(#9505), rabbit polyclonal antibody against COX IV
(#4844), rabbit polyclonal antibody against cytochrome
c (#4272), rabbit polyclonal antibody against PARP
(#9542) from Cell Signaling Technology (Danvers, MA,
USA), and mouse monoclonal antibody against actin
(AC-40, A3853) from Sigma-Aldrich.
Casp3 Silencer® Select Validated siRNA 4427038,
Casp7 Silencer® Select Validated siRNA 4427038, Casp8
Silencer® Select Validated siRNA 4427038, and Casp9Silencer® Select Validated siRNA 4427037 were from Life
technologies (Carlsbad, CA, USA).
Cells and culture conditions
Human breast carcinoma cell lines SK-BR-3 and MCF-7
were obtained from American Type Culture Collection
(ATCC, Rockville, MD, USA) and the National Cancer
Institute (Frederick, MD, USA), respectively. The cells
were maintained in a culture medium at 37°C in a hu-
midified atmosphere of 5% CO2 in air. The culture
medium consisted of basic medium supplemented with
10% heat-inactivated fetal bovine serum (Biochrom AG,
Berlin, Germany). The basic medium was RPMI 1640
medium (Sigma-Aldrich, St. Louis, MO, USA) contain-
ing extra L-glutamine (300 μg/ml), sodium pyruvate
(110 μg/ml), HEPES (15 mM), penicillin (100 U/ml) and
streptomycin (100 μg/ml) [42]. For experiments, pacli-
taxel and SB-T-1216 were diluted in culture medium to
produce a final concentration of 100 nM (SK-BR-3) and
300 nM (MCF-7). These cell death inducing concentra-
tions are the lowest taxane concentrations with nearly
maximum effect on tested cells. The concentrations
were derived from dose response experiments described
in detail previously [20]. DMSO was used as a dissolvent
agent for taxanes. DMSO itself at used concentrations
was found without any effect on tested cells.
Assessment of cell growth and survival
Cells were harvested and seeded at 20 × 103 cells/100 μl
of culture medium into the wells of a 96-well plastic
plate. After a 24-h preincubation period allowing cells to
attach, the culture medium was replaced by either cul-
ture medium without taxane (control) or medium with
one of tested taxanes (paclitaxel or SB-T-1216) at de-
sired concentrations. Cell growth and survival were eval-
uated after 48 h and 96 h of incubation. The number of
living cells was determined using a hemocytometer after
staining with trypan blue.
Preparation of cell lysates
Cells at desired concentrations were seeded into wells of
a plastic plate, Petri dishes or culture flasks and taxanes
were applied after a 24-h preincubation. After the incu-
bation period, cells were harvested by low-speed centri-
fugation (2000 rpm, 9 min, 4°C), washed in PBS and
centrifuged. Cell pellets were stored at -80°C. Frozen
pellets were resuspended in RIPA buffer (Sigma Aldrich)
containing a 1% mixture of protease inhibitors P8340
(AEBSF 104 mM, Aprotinin 80 μM, Bestatin 4 mM, E-
64 1.4 mM, Leupeptin 2 mM, Pepstain A 1.5 mM, Sigma
Aldrich). Protein lysates were centrifuged (14,000 rpm,
20 min, 4°C) and the supernatants containing proteins
were stored at -80°C. Protein lysates were than analyzed
using western blot.
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Cells (approximately 3.6 × 106 cells per sample) were
seeded into Petri dishes or culture flasks and taxanes
were applied after a 24-h preincubation. After the incu-
bation period, cells were harvested by low-speed centri-
fugation (2000 rpm, 9 min, 4°C), washed in PBS and
centrifuged again. Cell pellets were resuspended in a
specific lysis buffer (75 mM NaCl, 1 mM NaH2PO4,
8 mM Na2HPO4, 250 mM sucrose and 1% mixture of
protease inhibitors P8340 from Sigma Aldrich) contain-
ing 0.635 mM digitonin D141 (Sigma-Aldrich) and
vortexed for 30 s. Lysates were than centrifuged
(14,000 rpm, 1 min, 4°C) and supernatants (cytosolic
fractions) were removed and stored at -80°C. The spe-
cific lysis buffer described above containing 6.35 mM
digitonin D141 (Sigma-Aldrich) was added to the pellets
and suspensions were vortexed for 30 s and centrifuged
(14,000 rpm, 1 min, 4°C). After centrifugation, superna-
tants (mitochondrial fractions) were removed and stored
at −80°C. Cell fractions were analyzed using western
blot.
Western blot analysis
First, the concentration of proteins in cell lysates was
assessed using BCA Protein Assay Reagent from Pierce
(Thermo Fisher Scientific, Rockford, IL, USA).
Depending on protein concentration, cell lysates were
diluted in RIPA buffer to the gel-loading concentration
of proteins (2.5 μg/μl), mixed with equal volumes of
sample buffer (0.125 M Tris/HCl pH 6.8, 10% glycerol,
4% SDS, 0.25 M DTT) and heated for 5–7 min at 110°C.
Protein samples were separated using a protein electro-
phoresis (Bio-Rad, Hercules, CA). Proteins separated by
SDS-PAGE were blotted onto 0.2 μm nitrocellulose
membrane PROTRAN BA 83 (Whatman-Schleicher and
Schuell, Maidstone, UK) for 3 h at 0.25 A, using a Mini-
Protean II blotting apparatus (Bio-Rad). The membrane
was blocked with 5% non-fat dry milk or 5% BSA in
TBS for 15–20 min and incubated with the primary anti-
body at 4°C overnight. After the incubation, the mem-
brane was washed three times (5–10 min) with TBS
containing 0.1% Tween-20. Then it was incubated for
1–2 h with the corresponding horseradish peroxidase-
conjugated secondary antibody (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA). Afterward, the membrane
was washed (as described above) and the chemilumines-
cence signal was detected using the Supersignal reagents
from Pierce (Thermo Fisher Scientific) and a CCD de-
vice (Kodak).
RNA interference
Based on the manufacturer’s instructions (INTERFERin™
in vitro siRNA Transfection Protocol, Polyplus transfec-
tion™), RNA interference in SK-BR-3 and MCF-7 cellswas completed. The cells were seeded at 2.1 × 105 cells/
6 ml of culture medium into a Petri dish for a 24-h pre-
incubation. The siRNAs (see “Materials”) were diluted in
400 μl OPTI-MEM® I Reduced Serum Medium (Gibco,
Invitrogen™ Life Technologies, Carlsbad, CA, USA) to a
final concentration of 5 nM and the INTERFERin™
transfection agent (18 μl per reaction mixture) was
added. The mixture was intensively vortexed and incu-
bated for 10 min at room temperature to form a trans-
fection complex. The preincubation medium in Petri
dish was replaced by 4 ml of fresh culture medium.
Transfection mixture was added and gently mixed. Cells
were incubated in the presence of transfection com-
plexes for 72 h. After incubation, cells were harvested
into fresh culture medium and seeded at 2 × 105 cells/
ml for further analysis. The efficiency of gene silencing
using RNA interference was confirmed using western
blot analysis followed by densitometry: in the case of
SK-BR-3 cells 81% for caspase-3, 81% for caspase-7, 94%
for caspase-8 and 70% for caspase-9, and in the case of
MCF-7 cells 81% for caspase-7, 89% for caspase-8 and
61% for caspase-9.
Flow cytometric analysis of the mitochondrial membrane
potential (Δψm)
Cells (approximately 5 × 105 cells per sample) were
seeded into Petri dishes and taxanes were applied after a
24-h preincubation. After the incubation period, cells
were harvested by low-speed centrifugation (2000 rpm,
9 min, 4°C) and resuspended in PBS. To assess Δψm,
cells were incubated with 20 nM 3, 3′-dihexyloxacarbo-
cyanine iodide [DiOC6(3)] from Invitrogen (Grand
Island, USA) at 37°C for 20 min. As a negative control,
the cells were pre-incubated with 100 μM carbonyl cyan-
ide m-chlorophenylhydrazone (CCCP) (Sigma-Aldrich, St.
Louis, USA), a protonophore causing a complete disrup-
tion of the Δψm, at 37°C for 20 min. After incubation,
samples were kept on ice. The fluorescence of cells was
measured using a FACS Calibur cytometer (Becton
Dickinson, San Jose, CA, USA).
Confocal microscopy
Confocal microscopy was described previously [43].
Briefly, cells were seeded onto coverslips (approximately
2 × 105 cells per coverslip) and taxanes were applied
after 24 h of preincubation. After 36 h of incubation,
cells were stained with Mitotracker Red 480 (Molecular
Probes, Grand Island, USA), fixed with 4% paraformal-
dehyde at 37°C for 15 min and permeabilized with 0.1%
Triton X-100 in 4% paraformaldehyde for the next
15 min. After washing with PBS, cells were blocked with
Image-iT™ FX signal enhancer (Molecular Probes, Invi-
trogen, Eugene, OR, USA) for 30 min. Next, cells were
stained with the corresponding primary antibody at 4°C
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bated with the corresponding secondary antibody for
1 hour in the dark at room temperature. Finally, cells
were washed again with PBS. Stained cells on coverslips
were transferred onto a droplet of Vectashield® Mounting
Medium with DAPI (Vector Laboratories, Burlingame,
CA, USA) and sealed. Samples were analyzed using a
Leica TCS SP5 confocal microscope (Bannockburn, IL,
USA) with relevant excitation and emission wavelengths.
Statistical analysis
Statistical significance of differences was determined
using the Student’s t-test. P < 0.05 and P < 0.01 were con-
sidered statistically significant at the 5% and 1% levels,
respectively.
Competing interests
The authors declare that they have no competing of interests.
Author’s contribution
MJ carried out western blot experiments and worked on the manuscript, KB
carried out siRNA techniques and western blot experiments, MS carried out
measuring of mitochondrial membrane potential, VNF carried out confocal
microscopy and cell fractionation, JŠ participated in cell fractionation, JS
participated in western blot experiments, IZ and IO participated in the
preparation of SB-T-1216 taxane, JK coordinated the experiments and helped
to complete the manuscript. All authors read and approved the final
manuscript.
Acknowledgments
This work was supported by grant 301/09/0362 from the Grant Agency of
the Czech Republic (to J.K.); by research project PRVOUK P27 from the
Charles University in Prague, and by grant CA 103314 from the National
Cancer Institute, USA (to I.O.). The authors thank Mr. Thomas Secrest for
English revision.
Author details
1Department of Cell and Molecular Biology, Third Faculty of Medicine,
Charles University, Prague, Czech Republic. 2Institute of Chemical Biology and
Drug Discovery, State University of New York at Stony Brook, Stony Brook,
NY, USA.
Received: 29 January 2014 Accepted: 31 December 2014
References
1. Bedard PL, Di Leo A, Piccart-Gebhart MJ. Taxanes: optimizing adjutant
chemotherapy for early-stage breast cancer. Nat Rev Clin Oncol. 2010;7:22–36.
2. Ojima I, Slater JC, Michaud E, Kuduk SD, Bounaud PY, Vrignaud P, et al.
Syntheses and structure-activity relationships of the second-generation
antitumor taxoids: exceptional activity against drug-resistant cancer cells.
J Med Chem. 1996;39:3889–96.
3. Ferlini C, Raspaglio G, Mozzetti S, Cicchillitti L, Filippetti F, Gallo D, et al. The
seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome
paclitaxel resistance. Cancer Res. 2005;65:2397–405.
4. Galletti E, Magnani M, Renzulli ML, Botta M. Paclitaxel and docetaxel
resistance: molecular mechanisms and development of new generation
taxanes. Chem Med Chem. 2007;2:920–42.
5. Ehrlichová M, Koc M, Truksa J, Naďová Z, Václavíková R, Kovář J. Cell death
induced by taxanes in breast cancer cells: cytochrome C is released in
resistant but not in sensitive cells. Anticancer Res. 2005;25:4215–24.
6. Ojima I, Chen J, Sun L, Borella CP, Wang T, Miller ML, et al. Design, synthesis,
and biological evaluation of new-generation taxoids. J Med Chem.
2008;51:3203–21.
7. Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Mechanisms of Taxol
resistance related to microtubules. Oncogene. 2003;22:7280–95.8. Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A,
et al. Insights into the mechanism of microtubule stabilization by Taxol.
Proc Natl Acad Sci U S A. 2006;103:10166–73.
9. Yuan SY, Hsu SL, Tsai KJ, Yang CR. Involvement of mitochondrial pathway in
Taxol-induced apoptosis of human T24 bladder cancer cells. Urol Res.
2002;30:282–8.
10. Morse DL, Gray H, Payne CM, Gillies RJ. Docetaxel induces cell death through
mitotic catastrophe in human breast cancer cells. Mol Cancer Ther.
2005;4:1495–504.
11. Mediavilla-Varela M, Pacheco FJ, Almaguel F, Perez J, Sahakian E, Daniels TR,
et al. Docetaxel-induced prostate cancer cell death involves concomitant
activation of caspase and lysosomal pathways and is attenuated by LEDGF/
p75. Mol Cancer. 2009;8:68.
12. Vobořilová J, Němcová-Fürstová V, Neubauerová J, Ojima I, Zanardi I, Gut I,
et al. Cell death induced by novel fluorinated taxanes in drug-sensitive and
drug-resistant cancer cells. Invest New Drugs. 2011;29:411–23.
13. Mhaidat NM, Wang Y, Kejda KA, Zhang XD, Hersey P. Docetaxel-induced
apoptosis in melanoma cells is dependent on activation of caspase-2. Mol
Cancer Ther. 2007;6:752–61.
14. Kovář J, Ehrlichová M, Smejkalová B, Zanardi I, Ojima I, Gut I. Comparison of
cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast
cancer cells. Anticancer Res. 2009;29:2951–60.
15. von Haefen C, Wieder T, Essmann F, Schulze-Osthoff K, Dörken B, Daniel PT.
Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-
independent, caspases-3/-8-driven mitochondrial amplification loop.
Oncogene. 2003;22:2236–47.
16. Liao PC, Tan SK, Lieu CH, Jung HK. Involvement of endoplasmic reticulum in
paclitaxel-induced apoptosis. J Cell Biochem. 2008;104:1509–23.
17. Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR. Taxol induces
caspase-10-dependent apoptosis. J Biol Chem. 2004;279:51057–67.
18. Zhivotovsky B, Orrenius S. Caspase-2 function in response to DNA damage.
Biochem Biophys Res Commun. 2005;331:859–67.
19. Tinel A, Janssens S, Lippens S, Cuenin S, Logette E, Jaccard B, et al.
Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2
and pro-survival NF-kappaB pathway. EMBO J. 2007;26:197–208.
20. Jelínek M, Balušíková K, Kopperová D, Němcová-Fürstová V, Šrámek J,
Fiedlerová J, et al. Caspase-2 is involved in cell death induction by taxanes
in breast cancer cells. Cancer Cell Int. 2013;13:42.
21. Ho LH, Read SH, Dorstyn L, Lambrusco L, Kumar S. Caspase-2 is required for
cell death induced by cytoskeletal disruption. Oncogene. 2008;27:3393–404.
22. Wang YF, Chen CY, Chung SF, Chiou YH, Lo HR. Involvement of oxidative
stress and caspase activation in paclitaxel-induced apoptosis of primary
effusion lymphoma cells. Cancer Chemother Pharmacol. 2004;54:322–30.
23. Janssen K, Pohlmann S, Jänicke RU, Schulze-Osthoff K, Fischer U. Apaf-1 and
caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes
clonogenic survival during paclitaxel treatment. Blood. 2007;110:3662–72.
24. Drago-Ferrante R, Santulli A, Di Fjord R, Giuliano M, Calvaruso G, Tesoriere G,
et al. Low doses of paclitaxel potently induce apoptosis in human
retinoblastoma Y79 cells by up-regulating E2F1. Int J Oncol. 2008;33:677–87.
25. André N, Carré M, Brasseur G, Pourroy B, Kovacic H, Briand C, et al. Paclitaxel
targets mitochondria upstream of caspase activation in intact human
neuroblastoma cells. FEBS Lett. 2002;532:256–60.
26. Luo Y, Ling Y, Guo W, Pang J, Liu W, Fang Y, et al. Docetaxel loaded oleic
acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced
apoptosis through activation of caspase-2 in androgen independent
prostate cancer cells. J Control Release. 2010;147:278–88.
27. Mhaidat NM, Zhang XD, Jiang CC, Hersey P. Docetaxel-induced apoptosis of
human melanoma is mediated by activation of c-Jun NH2-terminal kinase
and inhibited by the mitogen-activated protein kinase extracellular signal-
regulated kinase 1/2 pathway. Clin Cancer Res. 2007;13:1308–14.
28. Kim JY, Chung JY, Lee SG, Kim YJ, Park JE, Yoo KS, et al. Nuclear interaction
of Smac/DIABLO with Survivin at G2/M arrest prompts docetaxel-induced
apoptosis in DU145 prostate cancer cells. Biochem Biophys Res Commun.
2006;350:949–54.
29. Chadderton A, Villeneuve DJ, Gluck S, Kirwan-Rhude AF, Gannon BR, Blair
DE, et al. Role of specific apoptotic pathways in the restoration of paclitaxel-
induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast
cancer cells. Breast Cancer Res Treat. 2000;59:231–44.
30. Flores ML, Castilla C, Ávila R, Ruiz-Borrego M, Sáez C, Japón MA. Paclitaxel
sensitivity of breast cancer cells requires efficient mitotic arrest and disruption
of Bcl-xL/Bak interaction. Breast Cancer Res Treat. 2012;133:917–28.
Jelínek et al. Cancer Cell International  (2015) 15:8 Page 16 of 1631. Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M. ZD6474
enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma
cells. J Cell Physiol. 2011;226:375–84.
32. Friedrich K, Wieder T, Von Haefen C, Radetzki S, Jänicke R, Schulze-Osthoff K,
et al. Overexpression of caspase-3 restores sensitivity for drug-induced
apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene.
2001;20:2749–60.
33. Perchellet EM, Crow KR, Gakhar G, Nguyen TA, Shi A, Hua DH, et al.
Bioactivity and molecular targets of novel substituted quinolines in murine
and human tumor cell lines in vitro. Int J Oncol. 2010;36:673–88.
34. Li Y, Xing D, Chen Q. Dynamic monitoring of apoptosis in chemotherapies
with multiple fluorescence reporters. Mol Imaging Biol. 2009;11:213–22.
35. Yang YI, Lee KT, Park HJ, Kim TJ, Choi YS, Shih IM, et al. Tectorigenin sensitizes
paclitaxel-resistant human ovarian cancer cells through downregulation of the
Akt and NFκB pathway. Carcinogenesis. 2012;33:2488–98.
36. Ofir R, Seidman R, Rabinski T, Krup M, Yavelsky V, Weinstein Y, et al. Taxol
induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells
is caspase-3 and caspase-9 independent. Cell Death Differ. 2002;9:636–42.
37. Mao HL, Liu PS, Zheng JF, Zhang PH, Zhou LG, Xin G, et al. Transfection of
Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-
induced apoptosis in vitro. Pharmacol Res. 2007;56:483–92.
38. Fabbri F, Amadori D, Carloni S, Brigliadori G, Tesei A, Ulivi P, et al. Mitotic
catastrophe and apoptosis induced by docetaxel in hormone-refractory
prostate cancer cells. J Cell Physiol. 2008;217:494–501.
39. Almubarak H, Jones A, Chaisuparat R, Zhang M, Meiller TF, Scheper MA.
Zoledronic acid directly suppresses cell proliferation and induces apoptosis
in highly tumorigenic prostate and breast cancers. J Carcinog. 2011;10:2.
40. Ajabnoor GM, Crook T, Coley HM. Paclitaxel resistance is associated with
switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells.
Cell Death Dis. 2012;3:260.
41. Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, Boise LH.
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic
apoptosis. BMC Cell Biol. 2013;14:32.
42. Musílková J, Kovář J. Additive stimulatory effect of extracellular calcium and
potassium on non-transferrin ferric iron uptake by HeLa and K562 cells.
Biochim Biophys Acta. 2001;1514:117–26.
43. Koc M, Nad’ová Z, Truksa J, Ehrlichová M, Kovář J. Iron deprivation induces
apoptosis via mitochondrial changes related to Bax translocation. Apoptosis.
2005;10:381–93.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
